The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Gene Expression, Immunological Status and Metabolome in Glioma Patients
Official Title: Monitoring and Analysis of Gene Expression, Immunological Status and Metabolome in Peripheral Blood Mononuclear Cells and Their Specific Subpopulations (CD4+ T Cells and CD56+ NK Cells) in Surgically Treated Glioma Patients
Study ID: NCT01525459
Brief Summary: Study on glioma patients treated with brain surgery is focusing on the analysis of their transcriptome expression profile measured in two immune cell populations, CD4+ T cells and CD56+ NK cells. The results of analysis will be compared to the reference data of healthy population. Furthermore, the metabolomic and immunological status will also be monitored and compared to healthy group reference data, before and after the surgery\*. With comparative crossomics analysis the investigators intend to possibly identify new diagnostic and prognostic biological markers for the relapse of the disease. The results are expected to convey a deeper insight into pathophysiology of the glioma as well as into the mechanisms of the current surgical therapy. \* The healthy reference data have been published in collaborative efforts of BTC, UMC and NIB (Gruden et al. 2012).
Detailed Description:
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Blood Transfusion Centre of Slovenia, Ljubljana, , Slovenia
Department of Neurosurgery, University Medical Centre Ljubljana, Ljubljana, , Slovenia
National Institute of Biology, Ljubljana, , Slovenia
Name: Tamara Lah Turnšek, PhD
Affiliation: National Institute of Biology, Ljubljana, Slovenia
Role: STUDY_CHAIR
Name: Kristina Gruden, PhD
Affiliation: National Institute of Biology, Ljubljana, Slovenia
Role: PRINCIPAL_INVESTIGATOR